Dyax Corp. Receives Positive Opinion for Orphan Medicinal Product Designation in the European Union for DX-2930 for the Treatment of Hereditary Angioedema
September 30, 2015 at 07:12 AM EDT
Dyax Corp. (NASDAQ: DYAX) today announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has ...
